Description
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog primarily used to reduce excess visceral abdominal fat in HIV-infected patients with lipodystrophy. It improves body composition by decreasing deep belly fat, enhancing metabolic profiles (reducing triglycerides/cholesterol), and potentially increasing lean muscle mass.
Key benefits of tesamorelin include:
Significant Visceral Fat Reduction: Clinical studies show a significant reduction in visceral adipose tissue (deep belly fat) of approximately 15-18% over 26 to 52 weeks of treatment.
Improved Metabolic Health: It lowers triglycerides and non-HDL cholesterol, and increases adiponectin levels, which can help manage fat and glucose metabolism
Increased Lean Muscle Mass: It can aid in improving overall body composition by increasing muscle mass, often noticed around 4–6 weeks of treatment.
Reduction in Liver Fat: Studies indicate that it may reduce liver fat (hepatic fat) in patients with HIV.
Improved Cardiovascular Health: It has been shown to reduce the intima-media thickness of the carotid arteries.
Enhanced Cognitive Function: Some studies suggest it can improve cognitive function in healthy adults and seniors.
Reviews
There are no reviews yet.